@bhalomanush @CinemaPaithiyam This could definitely work as a treatment option after they prove the efficacy and safety in a larger phase 3 study. This is a human mAb so, safer in terms of antigenicity.
@bhalomanush @CinemaPaithiyam This could definitely work as a treatment option after they prove the efficacy and safety in a larger phase 3 study. This is a human mAb so, safer in terms of antigenicity.